Journals / Göztepe Tıp Dergisi / 2003 / Cilt: 18 - Sayı: 2

The effects of oral hormone replacement therapy on pulsatility indeks of internal carotid artery and uterin artery

Oral hormon replasman tedavisinin internal karotis arter ve uterin arter pulsatilite indeksi üzerine olan etkileri

Pages
82–84
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean internal carotid artery pulsatilitl index was decreased from 1.28±0.32to 1.07±0.25 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to demonstrate the effects of oral hormone replacement theraphy on cardiovascular system at postmenopausal period by researching its effect on internal carotid artery and uterin artery.We worked on 30 patients who applied for our policlinic with menapousal complaints. 0.625 mg/day continue conjuge estrogen and last 12 days of the cyclus 5 mg/day medroxy-progesterone acetate treatment were given.
📊
Key Findings & Data:On the 3rd month of the treatment pulsatility index evaluation were repeated.After hormone replacement therapy the reductions n mean pulsatility index values of the internal carotid artery and uterine with respect to baseline were at a significant level.
💡
Conclusion & Impact:The mean internal carotid artery pulsatilitl index was decreased from 1.28±0.32to 1.07±0.25 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We aimed to demonstrate the effects of oral hormone replacement theraphy on cardiovascular system at postmenopausal period by researching its effect on internal carotid artery and uterin artery.We worked on 30 patients who applied for our policlinic with menapousal complaints. 0.625 mg/day continue conjuge estrogen and last 12 days of the cyclus 5 mg/day medroxy-progesterone acetate treatment were given. Color doppler ultrasonography was used to measure the impedance to flow (pulsatility index) within the internal carotid and uterine artery at baselin. On the 3rd month of the treatment pulsatility index evaluation were repeated.After hormone replacement therapy the reductions n mean pulsatility index values of the internal carotid artery and uterine with respect to baseline were at a significant level. The mean internal carotid artery pulsatilitl index was decreased from 1.28±0.32to 1.07±0.25 (p

Özet

Hormon replasman tedavisinin postmenopozal dönemde kardiyovasküler sisteme etkisini, internal karotis arter ve uterin arter pulsatilite indeksi üzerine etkisini araştırarak göstermeyi amaçladık.Menopozal şikayetler ile polikliniğimize başvuran 30 olgu çalışmaya alındı. Olgulara kesintisiz konjuge östrogen 0.625 mg/gün ve siklusun son 12 gününde 5 mg/gün medroksiprogesteron asetat tedavisi başlandı. İnternal karotid ve uterin arter pulsatilite indekslerinin bazal değerleri renkli doopler ultrasonografi kullanılarak ölçüldü. Tedavinin 3. ayında tekrar internal karotid ve uterin pulsatilite indeks değerlendirmesi yapıldı.Hormon replasman tedavisi sonrası internal karotis ve uterin arter ortalama pulsatilite indeks oranlarında anlamlı düzeyde azalma izlendi. Bazal ortalama internal karotis arter pulsatilite indeksi 1.28±0.32 iken, tedavi sonrası 1.07±0.25'e (p

🔖

Cite This Article

KANADIKIRIK, F., ESER, K. S., MEGA, E. (2022). The effects of oral hormone replacement therapy on pulsatility indeks of internal carotid artery and uterin artery. Göztepe Tıp Dergisi, Cilt: 18 - Sayı: 2, 82–84. https://ajindex.com/articles/651101

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Kişnişçi HA: Klimakteriıını ve Menopoz Kişnişçi HA, Gökşin E, Durukan T (ed). Temel Kadın Hastalıkları ve Doğum Bilgisi, Güneş Kitabevi, Ankara, 1319-51,1996 2.Speroffl: The Menopouse. Asignal for the future. Lobo RA (ed):Treatment of the menopausel women.Raven Press,New York. s. 1-8, 1994. 3. Sağlık. Bakanlığı (Türkiye);Hacettepe Üniversitesi Nüfus Etüdleri Enstitüsü, 1993,
  2. Ankara, Tükiye, 1994. 4. Ertüngealp E, Seyisoğlu H: Menopoz ve Osteoporoz. Ulusal Menopoz ve Osteoporoz Derneği Yayını, İstanbul, 96-7,2000. 5. Gorodeski GI: Mechanizm of action for estrogen in cardioprotection. In Progress in the Management of the" menopause. Wren BG (ed). The Pathenon Publishing Group, Lonon, 402-18,1997. 6. Fleischer AC, Ruth B, Golstein MD, et al: Doppler sonography in obstetric nd Gyncology 223-49, 1996. 7. Caciatore B, Paakkari I, Toivonen J, et al: Randomize comparision of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. Obstet Gyneocol 92:563-8, 8. Jackson S, Vyas S: A.double blind, placebo controlled study of postmenopkusal hormone replacement therapy and carotid artery pulsatility index.Brj Obstet Gyneocol 105:408-12, 1998. 9. Penotti M, Nencioni T, Gabrielli L, et al: Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gyneocol 169:-1226-32, 1993. 10.W.Marchien, van Baal, Kenemans P, Coen DA: Sequentially combined hormone, replacement therapy reduces impedance to flow within, the uterin and central retinal arteries in healty postmenopausel women.Am J Obstet Gyneocol 181:1365-73, 1999. 11. Lau TK, Wan D, Yim SF, et al: Prospective, randomize controlled study of the effect of hormone replacement therapy on peripheral blod flow velocity in postmenopausal women. Fertil Steril 70:284-8, 1998.